Product: SP100 Antibody
Catalog: DF4247
Description: Rabbit polyclonal antibody to SP100
Application: WB IHC IF/ICC
Reactivity: Human
Mol.Wt.: 0 KD; 100kD(Calculated).
Uniprot: P23497
RRID: AB_2836598

View similar products>>

   Size Price Inventory
 100ul $280 In stock
 200ul $350 In stock

Lead Time: Same day delivery

For pricing and ordering contact:
Local distributors

Product Info

Source:
Rabbit
Application:
WB 1:500-1:1000, IHC 1:50-1:200, IF/ICC 1:100-1:500
*The optimal dilutions should be determined by the end user.
*Tips:

WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.

Reactivity:
Human
Clonality:
Polyclonal
Specificity:
SP100 Antibody detects endogenous levels of total SP100.
RRID:
AB_2836598
Cite Format: Affinity Biosciences Cat# DF4247, RRID:AB_2836598.
Conjugate:
Unconjugated.
Purification:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
Storage:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
Alias:

Fold/Unfold

DKFZp686E07254; FLJ00340; FLJ34579; Lysp100b; Nuclear antigen Sp100; Nuclear autoantigen Sp 100; Nuclear autoantigen Sp-100; Nuclear autoantigen Sp100; Nuclear dot associated Sp100 protein; Nuclear dot-associated Sp100 protein; SP 100; SP100; SP100 HMG nuclear autoantigen; SP100 nuclear antigen; SP100_HUMAN; Speckled 100 kDa;

Immunogens

Immunogen:
Uniprot:
Gene(ID):
Expression:
P23497 SP100_HUMAN:

Widely expressed. Sp100-B is expressed only in spleen, tonsil, thymus, mature B-cell line and some T-cell line, but not in brain, liver, muscle or non-lymphoid cell lines.

Sequence:
MAGGGGDLSTRRLNECISPVANEMNHLPAHSHDLQRMFTEDQGVDDRLLYDIVFKHFKRNKVEISNAIKKTFPFLEGLRDRDLITNKMFEDSQDSCRNLVPVQRVVYNVLSELEKTFNLPVLEALFSDVNMQEYPDLIHIYKGFENVIHDKLPLQESEEEEREERSGLQLSLEQGTGENSFRSLTWPPSGSPSHAGTTPPENGLSEHPCETEQINAKRKDTTSDKDDSLGSQQTNEQCAQKAEPTESCEQIAVQVNNGDAGREMPCPLPCDEESPEAELHNHGIQINSCSVRLVDIKKEKPFSNSKVECQAQARTHHNQASDIIVISSEDSEGSTDVDEPLEVFISAPRSEPVINNDNPLESNDEKEGQEATCSRPQIVPEPMDFRKLSTFRESFKKRVIGQDHDFSESSEEEAPAEASSGALRSKHGEKAPMTSRSTSTWRIPSRKRRFSSSDFSDLSNGEELQETCSSSLRRGSGSQPQEPENKKCSCVMCFPKGVPRSQEARTESSQASDMMDTMDVENNSTLEKHSGKRRKKRRHRSKVNGLQRGRKKDRPRKHLTLNNKVQKKRWQQRGRKANTRPLKRRRKRGPRIPKDENINFKQSELPVTCGEVKGTLYKERFKQGTSKKCIQSEDKKWFTPREFEIEGDRGASKNWKLSIRCGGYTLKVLMENKFLPEPPSTRKKRILESHNNTLVDPCEEHKKKNPDASVKFSEFLKKCSETWKTIFAKEKGKFEDMAKADKAHYEREMKTYIPPKGEKKKKFKDPNAPKRPPLAFFLFCSEYRPKIKGEHPGLSIDDVVKKLAGMWNNTAAADKQFYEKKAAKLKEKYKKDIAAYRAKGKPNSAKKRVVKAEKSKKKKEEEEDEEDEQEEENEEDDDK

PTMs - P23497 As Substrate

Site PTM Type Enzyme
A2 Acetylation
S18 Phosphorylation
T39 Phosphorylation
Y50 Phosphorylation
K55 Ubiquitination
S65 Phosphorylation
K70 Ubiquitination
K87 Ubiquitination
S92 Phosphorylation
S111 Phosphorylation
K151 Ubiquitination
S157 Phosphorylation
S166 Phosphorylation
S171 Phosphorylation
T176 Phosphorylation
S180 Phosphorylation
S189 Phosphorylation
S191 Phosphorylation
T197 Phosphorylation
T198 Phosphorylation
K217 Ubiquitination
K219 Ubiquitination
T221 Phosphorylation
T222 Phosphorylation
S223 Phosphorylation
K225 Ubiquitination
S228 Phosphorylation
S231 Phosphorylation
T234 Phosphorylation
S247 Phosphorylation
S274 Phosphorylation
K297 Sumoylation
K298 Ubiquitination
K300 Acetylation
K300 Ubiquitination
K306 Acetylation
K306 Sumoylation
K306 Ubiquitination
S327 Phosphorylation
S328 Phosphorylation
S331 Phosphorylation
S334 Phosphorylation
T335 Phosphorylation
S350 Phosphorylation
S362 Phosphorylation
K366 Sumoylation
K366 Ubiquitination
K387 Sumoylation
S389 Phosphorylation
S394 Phosphorylation
K396 Sumoylation
S407 Phosphorylation
S409 Phosphorylation
S410 Phosphorylation
S419 Phosphorylation
K430 Acetylation
K430 Ubiquitination
S445 Phosphorylation
S451 Phosphorylation
S452 Phosphorylation
S453 Phosphorylation
S456 Phosphorylation
S459 Phosphorylation
S476 Phosphorylation
K486 Acetylation
S512 Phosphorylation
S524 Phosphorylation
T525 Phosphorylation
S530 Phosphorylation
K557 Ubiquitination
T560 Phosphorylation
K564 Ubiquitination
K594 Ubiquitination
K601 Ubiquitination
K613 Ubiquitination
K673 Ubiquitination
K731 Acetylation
K733 Acetylation
K733 Methylation
K733 Ubiquitination
K739 Acetylation
K739 Ubiquitination
K750 Ubiquitination
T751 Phosphorylation
Y752 Phosphorylation
K764 Acetylation
K764 Ubiquitination
K786 Ubiquitination
Y818 Phosphorylation
Y836 Phosphorylation

Research Backgrounds

Function:

Together with PML, this tumor suppressor is a major constituent of the PML bodies, a subnuclear organelle involved in a large number of physiological processes including cell growth, differentiation and apoptosis. Functions as a transcriptional coactivator of ETS1 and ETS2 according to. Under certain conditions, it may also act as a corepressor of ETS1 preventing its binding to DNA according to. Through the regulation of ETS1 it may play a role in angiogenesis, controlling endothelial cell motility and invasion. Through interaction with the MRN complex it may be involved in the regulation of telomeres lengthening. May also regulate TP53-mediated transcription and through CASP8AP2, regulate FAS-mediated apoptosis. Also plays a role in infection by viruses, including human cytomegalovirus and Epstein-Barr virus, through mechanisms that may involve chromatin and/or transcriptional regulation.

PTMs:

Sumoylated. Sumoylation depends on a functional nuclear localization signal but is not necessary for nuclear import or nuclear body targeting.

Sumoylated. Sumoylated with SUMO1. Sumoylation depends on a functional nuclear localization signal but is not necessary for nuclear import or nuclear body targeting. Sumoylation may stabilize the interaction with CBX5.

Subcellular Location:

Nucleus. Nucleus>PML body. Cytoplasm.
Note: Differences in the subnuclear localization of the different isoforms seem to exist and may also be cell cycle- and interferon-dependent. Accumulates in the cytoplasm upon FAS activation.

Nucleus.
Note: Forms a reticulate or track-like nuclear pattern with denser concentrations at the nuclear lamina and surrounding the nucleoli, a pattern reminiscent of heterochromatin-rich regions according to PubMed:11313457.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location
Tissue Specificity:

Widely expressed. Sp100-B is expressed only in spleen, tonsil, thymus, mature B-cell line and some T-cell line, but not in brain, liver, muscle or non-lymphoid cell lines.

Subunit Structure:

Homodimer; isoforms are able to heterodimerize. Interacts with members of the HP1 family of nonhistone chromosomal protein, such as CBX5 and CBX3 via the PxVxL motif. Interacts with ETS1; the interaction is direct and modulates ETS1 transcriptional activity. Interacts with the MRN complex which is composed of two heterodimers RAD50/MRE11 associated with a single NBN; recruits the complex to PML-related bodies. Interacts with HIPK2; positively regulates TP53-dependent transcription. Interacts with CASP8AP2; may negatively regulate CASP8AP2 export from the nucleus to the cytoplasm. Interacts with SUMO1P1/SUMO5.

(Microbial infection) Interacts with Epstein-Barr virus EBNA-LP; this interaction is important for EBNA-LP coactivator activity.

(Microbial infection) Interacts with human cytomegalovirus/HHV-5 protein UL123; may play a role in infection by the virus.

Family&Domains:

The HSR domain is important for the nuclear body targeting as well as for the dimerization.

Contains one Pro-Xaa-Val-Xaa-Leu (PxVxL) motif, which is required for interaction with chromoshadow domains. This motif requires additional residues -7, -6, +4 and +5 of the central Val which contact the chromoshadow domain.

Research Fields

· Human Diseases > Infectious diseases: Viral > Herpes simplex infection.

· Human Diseases > Cancers: Overview > Viral carcinogenesis.

Restrictive clause

 

Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.

For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.